D'Andrea, D., Black, P. C., Zargar, H., Dinney, C. P., Soria, F., Cookson, M. S., Montgomery, J. S., Kassouf, W., Dall'Era, M. A., Sridhar, S. S., McGrath, J. S., Wright, J. L., Thorpe, A. C., Holzbeierlein, J. M., Carrión, D. M., Di Trapani, E., Bivalacqua, T. J., North, S., Barocas, D. A., Lotan, Y., Grivas, P., Stephenson, A. J., van Rhijn, B. W., Daneshmand, S., Spiess, P. E., Shariat, S. F., & , (2022). identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer. Journal of urology, 207(1), 70–76. http://access.bl.uk/ark:/81055/vdc_100146771505.0x00000b